GORI SAVELLINI, GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 2.705
EU - Europa 2.081
AS - Asia 265
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 3
OC - Oceania 1
Totale 5.062
Nazione #
US - Stati Uniti d'America 2.700
IE - Irlanda 600
IT - Italia 325
GB - Regno Unito 322
SE - Svezia 231
CN - Cina 180
UA - Ucraina 157
FR - Francia 128
DE - Germania 104
FI - Finlandia 91
RU - Federazione Russa 79
SG - Singapore 37
VN - Vietnam 16
ES - Italia 13
CZ - Repubblica Ceca 10
EU - Europa 7
BE - Belgio 6
HK - Hong Kong 6
IN - India 5
TR - Turchia 4
CA - Canada 3
CH - Svizzera 3
IR - Iran 3
JP - Giappone 3
AT - Austria 2
BG - Bulgaria 2
BR - Brasile 2
ID - Indonesia 2
IM - Isola di Man 2
KR - Corea 2
PK - Pakistan 2
TH - Thailandia 2
AL - Albania 1
AU - Australia 1
BZ - Belize 1
CL - Cile 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LU - Lussemburgo 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 5.062
Città #
Dublin 583
Fairfield 396
Chandler 307
Southend 275
Ashburn 243
Woodbridge 222
Seattle 176
Wilmington 170
Siena 150
Cambridge 146
Houston 130
Jacksonville 127
Princeton 105
Ann Arbor 90
Helsinki 62
New York 42
Menlo Park 40
Nanjing 38
Fremont 36
Beijing 25
Boardman 25
San Diego 22
Rome 21
Moscow 20
Florence 19
San Mateo 18
Dong Ket 14
Nanchang 14
Norwalk 14
Singapore 14
Hebei 11
Lancaster 11
Shanghai 11
Shenyang 11
Málaga 10
London 8
Venezia 8
Kunming 7
Tianjin 7
Brussels 6
Hong Kong 6
Munich 6
San Francisco 6
Olomouc 5
Poli 5
Brno 4
Changsha 4
Hounslow 4
Izmir 4
Jinan 4
Massa 4
Ningbo 4
Pescara 4
Redwood City 4
Bonndorf 3
Chicago 3
Jiaxing 3
Kilburn 3
Lanzhou 3
Lappeenranta 3
Los Angeles 3
Milan 3
Modena 3
Redmond 3
San Jose 3
Voghera 3
Yantai 3
Dearborn 2
Empoli 2
Haikou 2
Hangzhou 2
Hanover 2
Leawood 2
Livorno 2
Lucca 2
Madrid 2
Messina 2
New Bedfont 2
Philadelphia 2
Pisa 2
Pistoia 2
Ratchathewi 2
Toronto 2
Trieste 2
Vienna 2
Washington 2
Zanjan 2
Zhengzhou 2
Americana 1
Andover 1
Bagnacavallo 1
Belgrade 1
Belize City 1
Bishkek 1
Boston 1
Budapest 1
Busto Arsizio 1
Buti 1
Casalecchio di Reno 1
Changchun 1
Totale 3.791
Nome #
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 227
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 219
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 180
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 156
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 139
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 139
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 138
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 135
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus. 130
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 130
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. 126
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 126
Diagnostic tools for Toscana virus infection. 122
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 122
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 122
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 117
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 114
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 114
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 114
null 112
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia. 106
Development of a mouse model for the study of Toscana virus pathogenesis 105
null 103
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 101
Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily. 100
null 94
null 94
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 92
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 90
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 84
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 83
Identification of a neutralizing epitope on tosv gn glycoprotein 75
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 73
How long can SARS-CoV-2 persist in human corpses? 73
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 69
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 68
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 65
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 59
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 58
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 56
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 52
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 52
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 51
Comparative performance of a new sars-cov-2 rapid detection system 50
null 41
Development of a vaccine against hRSV and hPIV3 using a replication deficient Sendai virus vector. 39
A novel replication deficient paramyxovirus elicits strong virus neutralising antibody and T cell responses in mice. 37
CD40L gene assembled to Immune-Reconstituted Influenza Virosome (IRIV) enhances the immunological and protective activity of a CEA anti-cancer vaccine. 35
Development of a vaccine against Toscana Virus. 33
Toscana virus epidemiology: from Italy to beyond. 32
Seroprevalence and risk factors for Toscana and Sicilian Virus infection in a sample population of Sicily (Italy). 31
Degradation of RIG-I and inhibition of IFN-beta induction by Toscana Virus NSs protein. 30
Prevalence of Toscana and Sicilian phlebovirus antibodies in classic Kaposi’s sarcoma cases and control subjects in Sicily 26
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 26
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 25
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 25
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 25
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells 22
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 22
RIG-I-mediated antiviral signalling is inhibited by toscana virus NSs protein. 22
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 17
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein 16
Toscana virus induces IFN-β production by activation of the cellular sensor RIG-I. 16
RECOGNITION OF TOSCANA VIRUS NSs REGIONS INVOLVED IN RIG-I DEGRADATION AND IFN-b INHIBITION 16
Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication 10
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 8
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 3
Totale 5.192
Categoria #
all - tutte 20.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020742 0 38 55 151 61 67 65 107 76 60 12 50
2020/2021807 25 59 18 49 56 185 71 89 76 47 61 71
2021/2022613 34 49 22 30 23 18 32 51 69 55 68 162
2022/20231.051 60 108 137 124 113 228 17 93 101 22 34 14
2023/2024958 30 50 74 74 36 224 343 17 7 12 13 78
2024/2025126 71 55 0 0 0 0 0 0 0 0 0 0
Totale 5.192